Pamidronate is a nitrogen-containing bisphosphonate medication primarily used to treat conditions characterized by excessive bone resorption, such as Paget's disease of bone, osteoporosis, and hypercalcemia… Read more
Pamidronate is a nitrogen-containing bisphosphonate medication primarily used to treat conditions characterized by excessive bone resorption, such as Paget's disease of bone, osteoporosis, and hypercalcemia associated with malignancy. By inhibiting osteoclast-mediated bone resorption, this drug helps regulate bone metabolism and calcium levels. Laboratories involved in pharmaceutical development and quality control require high-quality reference standards for pamidronate to ensure accurate analytical results. This category offers a comprehensive selection of pamidronate reference standards, including pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds. These materials are essential for impurity profiling, validating analytical methods, and performing reliable quantitative analysis during the stability testing and release of pharmaceutical products. Utilizing these standardized compounds supports precise measurement and adherence to regulatory requirements throughout the drug development lifecycle.